Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sultiam (N03AX03), nur Filmtabletten im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (B03XA01) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (L04AB06) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Vaginalring mit Gestagenen und Estrogenen (G02BB01) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Clobetasol (D07AD01) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Bosutinib (L01EA04) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim (L03AA02) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sulfasalazin (M01CX02) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgotinib (L04AF04) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Edoxaban (B01AF03) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Imiquimod (D06BB10) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Ebastin (R06AX22) im Rahmen eines sogenannten Open-House-Modells.
ted.europa.eu
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naproxen exklusive der Darreichung Sirup (ATC-Code nach WHO: M01AE02)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-07 - Dapagliflozin
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Miglustat (ATC-Code nach WHO: A16AX06)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-06 - Aclidiniumbromid/Formoterol (Wirkstoffkombination)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: G04BX21)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: C03XA01)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
GRA
ROSES 2025: A.4 Rapid Response and Novel Research in Earth Science
grants.gov
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to r...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/31/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: March 30, 2026. A new requirement has been added to Section 1 and the point of contact for the NASA flight request system in Section 5.1.1 has been updated. New text is in bold and deleted text is struck through. NOTICE: Amended, January 22, 2026. The last date for submission of proposals in Section 6 has been updated to reflect that ROSES-25 rolling submissions will be open through August 2026. Also, the p...
GRA
ROSES 2025: A.10 INNOVATE
grants.gov
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to r...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineAug 31, 2026
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/31/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: Amended, January 26, 2026. Sections 1 and 1.1 have been updated to encourage non-governmental organizations new to NASA to partner with NASA centers, and a requirement was added to Section 4 to plan for operation beyond the award period. New text is in bold and deleted text is struck through. NOTICE: Amended, January 22, 2026. The last date for submission of proposals (in Section 7) has been updated to refl...
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
38151
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Erythropoietin (ATC: B03XA01 - in der Wirkstärke über 10.000 IE je Dosiereinheit)Buyer: AOK Sachsen - Anhalt | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sultiam (N03AX03), nur Filmtabletten im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38154
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (B03XA01) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38155
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (L04AB06) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38156
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Vaginalring mit Gestagenen und Estrogenen (G02BB01) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38157
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Clobetasol (D07AD01) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38158
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Bosutinib (L01EA04) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38159
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim (L03AA02) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38160
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sulfasalazin (M01CX02) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38161
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Filgotinib (L04AF04) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38162
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Edoxaban (B01AF03) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38163
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Imiquimod (D06BB10) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38164
Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Ebastin (R06AX22) im Rahmen eines sogenannten Open-House-Modells.Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38165
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naproxen exklusive der Darreichung Sirup (ATC-Code nach WHO: M01AE02)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38166
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-07 - DapagliflozinBuyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Miglustat (ATC-Code nach WHO: A16AX06)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38168
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-06 - Aclidiniumbromid/Formoterol (Wirkstoffkombination)Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: G04BX21)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38172
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tolvaptan (ATC-Code: C03XA01)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
Buyer: AOK Rheinland/Hamburg - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-08-31
38174
ROSES 2025: A.4 Rapid Response and Novel Research in Earth ScienceThis program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/31/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: March 30, 2026. A new requirement has been added to Section 1 and the point of contact for the NASA flight request system in Section 5.1.1 has been updated. New text is in bold and deleted text is struck through. NOTICE: Amended, January 22, 2026. The last date for submission of proposals in Section 6 has been updated to reflect that ROSES-25 rolling submissions will be open through August 2026. Also, the points of contact have been updated. New text is in bold and deleted text is struck through. NOTICE: Amended September 22, 2025. This amendment announces that those proposing to Earth Science (ROSES Appendix A) to use the NASA Center for Climate Simulation high-end computing facility must include $0.09/SBU in their budget per the instructions provided in Section 7.3 of ROSES-25 A.1 Earth Science Research Overview. This applies to all open and future program elements in Appendix A (Earth Science) as of 09/22/2025. This synopsis is a generic summary that is posted for each of the many individua...
38175
ROSES 2025: A.10 INNOVATEThis program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
This program element does not have a proposal due date. Proposals may be submitted at any time, pending certain eligibility timing issues related to resubmissions and duplicate proposal avoidance, see the program element text and appropriate overview appendix (e.g., B.1 or C.1). The date shown of 8/31/2026 is the last day that proposals may be submitted subject to the ROSES-25 rules and the current GCAM. The ROSES-26 version of this program element is planned to overlap with this ROSES-25 version by a few weeks, allowing continuous submission of proposals across ROSES years. NOTICE: Amended, January 26, 2026. Sections 1 and 1.1 have been updated to encourage non-governmental organizations new to NASA to partner with NASA centers, and a requirement was added to Section 4 to plan for operation beyond the award period. New text is in bold and deleted text is struck through. NOTICE: Amended, January 22, 2026. The last date for submission of proposals (in Section 7) has been updated to reflect that ROSES-25 will be open until August 2026. Proposals may be submitted at any time until August 31, 2026. New text is in bold and deleted text is struck through. NOTICE: Amended September 22, 2025. This amendment announces that those proposing to Earth Science (ROSES Appendix A) to use the NASA Center for Climate Simulation high-end computing facility must include $0.09/SBU in their budget per the instructions provided in Section 7.3 of ROSES-25 A.1 Earth Science Research Overview. This applies to all open and future program elements in Appendix A (Earth Science) as of 09/22/2025. This....
No saved opportunities on this page. Use the star icon near an opportunity title.
